Last Modified: March 11, 2024

Ashleigh Raso is an award-winning attorney and founding partner at Nigh, Goldenberg, Raso & Vaugn.  She practices product liability law with a concentration on medical device and pharmaceutical drugs. Raso is licensed in several federal courts as well as Minnesota state court and some tribal courts. 

Raso has been named Super Lawyers Rising Star for three straight years. Her mass tort leadership experience includes: 

  • Florida Exactech Litigation
  • Stryker LFIT V40 Femoral Head Products Liability Litigation
  • Zimmer M/L Taper Hip Prosthesis or M/L Taper Hip Prosthesis with Kinectiv Technology and Versys Femoral Head Products
  • Valsartan NDMA Contamination Products Liability Litigation 
  • Wright Profemur Litigation

Raso combines her skills and unique background to represent people injured by a medical device or pharmaceutical drug. She believes strongly in the 7th Amendment and the right to trial by jury.

When not practicing law, Raso serves on the board of Canine Inspired Change, a non-profit that works with underprivileged you and therapy dogs. She can also be found with her friends and family, on the volleyball court, or with her dog, Baileigh.

 

Bar and Court Admissions

  • 2012, Minnesota
  • 2013, U.S. District Court of Minnesota
  • 2014, U.S. District Court for the Northern District of Texas
  • 2014, Admitted to practice on an annual basis before the tribal courts of the Prairie Island Indian Community and the Mille Lacs Band of Ojibwe
  • 2015, U.S. District Court for the Western District of Wisconsin
  • 2016, 8th Circuit Court of Appeals
  • 2018, Eastern District of Michigan

Affiliations

  • American Association of Justice – Member
  • Minnesota Association of Justice 2012- Member

About Drugwatch’s Experts

Drugwatch’s experts are authorities in their fields. Their personal experiences and professional expertise make them uniquely qualified to review our content for accuracy and verify that the information you read here is trustworthy, comprehensive and consistent with the latest evidence-based research.

More About Our Experts